Benchmark Maintains Buy on Regeneron Pharmaceuticals, Raises Price Target to $636

Over the past 3 months, 6 analysts have published their opinion on NextEra Energy (NYSE:NEE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.